| Chemokine analysis in patients with metastatic uveal melanoma suggests a role for CCL21 signaling in combined epigenetic therapy and checkpoint immunotherapy VR Sah, H Jespersen, J Karlsson, LM Nilsson, M Bergqvist, I Johansson, ... Cancer Research Communications 3 (5), 884-895, 2023 | 1 | 2023 |
| Moles and melanoma H Jespersen Tidsskrift for Den norske legeforening, 2022 | | 2022 |
| Føflekker og melanom H Jespersen Tidsskrift for Den norske legeforening, 2022 | | 2022 |
| Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma VR Sah, J Karlsson, H Jespersen, MF Lindberg, LM Nilsson, L Ny, ... Melanoma Research 32 (4), 241-248, 2022 | 15 | 2022 |
| Refleksjon om kurasjon H Jespersen Tidsskrift for Den norske legeforening, 2021 | | 2021 |
| The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma L Ny, H Jespersen, J Karlsson, S Alsén, S Filges, C All-Eriksson, ... Nature communications 12 (1), 5155, 2021 | 110 | 2021 |
| Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in uveal melanoma VR Sah, H Jespersen, J Karlsson, MF Lindberg, LM Nilsson, L Ny, ... bioRxiv, 2021.02. 04.429575, 2021 | 1 | 2021 |
| Surgery of metastatic melanoma after systemic therapy–the SUMMIST trial: study protocol for a randomized controlled trial CJ Holmberg, D Katsarelias, H Jespersen, A Carneiro, NO Elander, ... Acta Oncologica 60 (1), 52-55, 2021 | 6 | 2021 |
| Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis S Bjursten, A Pandita, Z Zhao, C Fröjd, L Ny, C Jensen, T Ullerstam, ... Journal for Immunotherapy of Cancer 9 (7), 2021 | 10 | 2021 |
| Molecular profiling of driver events in metastatic uveal melanoma J Karlsson, LM Nilsson, S Mitra, S Alsén, GV Shelke, VR Sah, ... Nature communications 11 (1), 1894, 2020 | 123 | 2020 |
| A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma (vol 9, 810, 2018) BO Einarsdottir, J Karlsson, E Soderberg, MF Lindberg, E Funck-Brentano, ... CELL DEATH & DISEASE 11 (2), 2020 | | 2020 |
| Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma BO Einarsdottir, J Karlsson, EMV Söderberg, MF Lindberg, ... Cell Death & Disease 11 (2), 2020 | | 2020 |
| Nivoilp Trial-A Phase Ib/II Randomized Double-Blind Placebo-Controlled Trial Evaluating the Effect of Nivolumab for Patients with In-Transit Melanoma Metastases Treated with … RO Bagge, A van Akkooi, D Grünhagen, L Been, M Wouters, W van Houdt, ... European Journal of Surgical Oncology 46 (2), e133, 2020 | | 2020 |
| Surgery of melanoma metastases after systemic therapy-the SUMMIST trial CJ Holmberg, D Katsarelias, H Jespersen, L Ny, RO Bagge European Journal of Surgical Oncology 46 (2), e14, 2020 | | 2020 |
| Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models L Ny, LY Rizzo, V Belgrano, J Karlsson, H Jespersen, L Carstam, ... Annals of Oncology 31 (2), 266-273, 2020 | 40 | 2020 |
| Translational studies of metastatic melanoma in the era of immunotherapy-from humanized mouse models to clinical trials H Jespersen | | 2020 |
| Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study H Jespersen, R Olofsson Bagge, G Ullenhag, A Carneiro, H Helgadottir, ... BMC cancer 19, 1-7, 2019 | 52 | 2019 |
| Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study) H Jespersen, RO Bagge, G Ullenhag, A Carneiro, H Helgadottir, ... Annals of Oncology 30, v907, 2019 | 12 | 2019 |
| Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanoma J Karlsson, LM Nilsson, EMV Forsberg, S Mitra, S Alsén, G Shelke, ... bioRxiv, 742023, 2019 | 3 | 2019 |
| Real-world data on PD-1 inhibitor therapy in metastatic melanoma A Arheden, J Skalenius, S Bjursten, U Stierner, L Ny, M Levin, ... Acta Oncologica 58 (7), 962-966, 2019 | 31 | 2019 |
